Please Wait
Applying Filters...
menu
    • menu
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Ibudilast

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Nihon Rikagaku
    Japan
    		 Nippon Rika Pharmaceuticals Co., Ltd. 219MF10339 Japanese Pharmacopoeia Ibudilast 2007-11-21 2007-11-21 4-2-2 Nihonbashi Honcho, Chuo Ward, Tokyo
    26/09/2024 Nihon Rikagaku
    Japan
    		 Nippon Rika Pharmaceuticals Co., Ltd. 217MF10064 External Regulations Ibudilast 2005-05-20 2006-03-09 4-2-2 Nihonbashi Honcho, Chuo Ward, Tokyo